Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | TSHR | P16473 | 4/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.61 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.61 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.57 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.48 |
| ▸ | PPARG | P37231 | 4/20 | 0.48 |
| ▸ | PPARD | Q03181 | 4/20 | 0.48 |
| ▸ | PPARA | Q07869 | 4/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL503466 | 0.97 | TSHR (0.67) | LMNATSHRNFKB1PMP22FOLH1 | |
| SCHEMBL503360 | 0.97 | TSHR (0.67) | LMNATSHRNFKB1PMP22FOLH1 | |
| SCHEMBL11622180 | 0.97 | TSHR (0.67) | LMNATSHRNFKB1PMP22FOLH1 | |
| SCHEMBL10861269 | 0.97 | TSHR (0.67) | LMNATSHRNFKB1PMP22FOLH1 | |
| SCHEMBL284957 | 0.94 | SLC22A6 (0.65) | LMNATSHRNFKB1PMP22FOLH1 | |
| SCHEMBL9185822 | 0.94 | LMNA (0.53) | LMNATSHRNFKB1PMP22FOLH1 | |
| SCHEMBL12568555 | 0.91 | LMNA (0.69) | LMNATSHRNFKB1PMP22FOLH1 | |
| SCHEMBL11438692 | 0.91 | TSHR (0.56) | LMNATSHRNFKB1PMP22FOLH1 | |
| SCHEMBL8751902 | 0.91 | TSHR (0.56) | LMNATSHRNFKB1PMP22FOLH1 | |
| SCHEMBL6265240 | 0.91 | TSHR (0.56) | LMNATSHRNFKB1PMP22FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-10273476-A | — | — | None | — | — | JP | disclosed |
| US-20240141397-A1 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BIOSYNTHESIZED TARGET PRODUCTS HAVING REDUCED LEVELS OF BYPRODUCTS | AGAIN BIO APS (DK) | 2024-05-02 | — | — | US | disclosed |
| US-20190300918-A1 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BIOSYNTHESIZED TARGET PRODUCTS HAVING REDUCED LEVELS OF BYPRODUCTS | AGAIN BIO APS (DK) | 2019-10-03 | — | — | US | disclosed |
| EP-3314002-A1 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BIOSYNTHESIZED TARGET PRODUCTS HAVING REDUCED LEVELS OF BYPRODUCTS | Genomatica, Inc. (US) | 2018-05-02 | — | — | EP | disclosed |
| WO-2016209883-A1 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BIOSYNTHESIZED TARGET PRODUCTS HAVING REDUCED LEVELS OF BYPRODUCTS | GENOMATICA, INC. (US) | 2016-12-29 | — | — | WO | disclosed |
| US-8435718-B2 | Upper layer-forming composition and photoresist patterning method | JSR CORPORATION (JP) | 2013-05-07 | — | — | US | disclosed |
| EP-1950610-B1 | IMMERSION LITHOGRAPHIC COMPOSITION FOR FORMING UPPER FILM AND METHOD FOR FORMING PHOTORESIST PATTERN | JSR CORP (JP) | 2012-05-02 | — | — | EP | disclosed |
| US-20120028198-A1 | UPPER LAYER-FORMING COMPOSITION AND PHOTORESIST PATTERNING METHOD | JSR CORPORATION (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20100003615-A1 | UPPER LAYER-FORMING COMPOSITION AND PHOTORESIST PATTERNING METHOD | JSR CORPORATION (JP) | 2010-01-07 | — | — | US | disclosed |
| EP-1950610-A1 | COMPOSITION FOR FORMING UPPER FILM AND METHOD FOR FORMING PHOTORESIST PATTERN | JSR Corporation (JP) | 2008-07-30 | — | — | EP | disclosed |
| EP-1758913-A1 | RUTHENIUM COMPLEXES OF PHOSPHINE-AMINOPHOSPHINE LIGANDS | EASTMAN CHEMICAL COMPANY (US) | 2007-03-07 | — | — | EP | disclosed |
| WO-2006012027-A1 | RUTHENIUM COMPLEXES OF PHOSPHINE-AMINOPHOSPHINE LIGANDS | EASTMAN CHEMICAL COMPANY (US) | 2006-02-02 | — | — | WO | disclosed |
| US-6939981-B1 | ruthenium complexes of phosphine-aminophosphine ligands are useful as catalyst for the asymmetric hydrogenation of beta -ketoesters to beta -hydroxyesters | EASTMAN CHEMICAL COMPANY (US) | 2005-09-06 | — | — | US | disclosed |
| EP-1176135-B1 | Process for producing optically active alcohol | TAKASAGO PERFUMERY CO LTD (JP) | 2005-06-15 | — | — | EP | disclosed |
| US-6492545-B2 | Process for producing optically active alcohol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-12-10 | — | — | US | disclosed |
| US-20020035283-A1 | Process for producing optically active alcohol | TAKASAGO INTERNATIONAL CORPORATION | 2002-03-21 | — | — | US | disclosed |
| EP-1176135-A1 | Process for producing optically active alcohol | Takasago International Corporation (JP) | 2002-01-30 | — | — | EP | disclosed |
| US-6229042-B1 | INTERMEDIATES FOR THE SYNTHESIS OF ENANTIOMERICALLY PURE ALPHA-LIPOIC ACID; SAID HYDROGENATION INCLUDES PRESENCE OF RUTHENIUM-PHOSPHINE COMPLEX | ASTA MEDICA AKTIENGESELLSCHAFT (DE) | 2001-05-08 | — | — | US | disclosed |
| US-6013833-A | USING A CATALYST OF A COMPLEX OF RUTHENIUM AND AN OPTICALLY ACTIVE PHOSPHINE; PRODUCING (R)-3-HYDROXYOCTANEDIOIC ACID DIESTERS AS CHEMICAL INTERMEDIATES OF ALPHA-LIPOIC ACID | ASTA MEDICA AKTIENGESELLSCHAFT (DE) | 2000-01-11 | — | — | US | disclosed |
| JP-H10273476-A | PRODUCTION OF ENANTIOMER PURE DIESTER OF 3-HYROXYOCTANEDIOIC ACID, DIESTER OF (R)-3-HYDROXYOCTANEDIOIC ACID AND PRODUCTION OF (R)-(+)-AND (S)-(-)-ALFA-LIPOIC ACID | ASTA MEDICA AG | 1998-10-13 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020035283-A1 | Process for producing optically active alcohol | ADH1A, ADH5, ADH1C | LMNA 4480/4885TSHR 2757/4885NFKB1 617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.